← brief for 2026-08-13 · Slowing decline

Hyperkalemia Risk After Finerenone Initiation in Diabetic Kidney Disease with Elevated Baseline Potassium: A Multicenter Cohort Study.

Article C Peer reviewed Observational

Key takeaways

Finerenone may cause hyperkalemia (high potassium) in patients with diabetic kidney disease. This multicenter study used data from 1,200 patients to assess risk.

Who did this work

Güven AT · Yadigar S · Özdede M · Akgür S · Arslan F · Sezen M · Özcan B · Ayaz EY · Doğantekin B · Atay İ · Değer SM · Demir M

Source

Article · PubMed, the drug frontier · 2026 Jul 23
https://pubmed.ncbi.nlm.nih.gov/42589862/